Acadia Pharmaceuticals developed and commercialized medicines in the United States on August 15, 2025.
3 reports, 2 independent
Updated Aug 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Acadia Pharmaceuticals developed and commercialized medicines in the United States on August 15, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Acadia Pharmaceuticals
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Simply Wall St.High Growth Tech Stocks To Watch In The US August 2025 As the U.S. market experiences a mix of record highs and tempered expectations due to recent inflation reports, investors are closely monitoring
- Business WireAcadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview - Second quarter total revenues of $264.6 million, up 9% year-over-year - Second quarter NUPLAZID® (pimavan
- Simply Wall St.High Growth Tech Stocks In The US For July 2025 As the U.S. stock market continues to flirt with record highs, driven by strong earnings reports and investor optimism, the tech-heavy Nasdaq Composite